DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
BORNEOL
1
Small molecule
Investigational
Unknown
Unknown
Angina, Stable
Unknown
BORNEOL
×
Maximum Phase:
1
First Approval:
None
UNII:
M89NIB437X
Molecule Type:
Small molecule
Molecular Formula:
C10H18O
Molecular Weight:
154.25
AlogP:
2.19
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ORVACABTAGENE AUTOLEUCEL
1
Gene
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
ORVACABTAGENE AUTOLEUCEL
×
Maximum Phase:
1
First Approval:
None
UNII:
K8RW1TW3EM
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SULTHIAME
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy
Carbonic anhydrase inhibitor
SULTHIAME
×
Maximum Phase:
1
First Approval:
None
UNII:
I00Q766CZ2
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O4S2
Molecular Weight:
290.37
AlogP:
0.26
PSA:
97.54
HBD:
1.0
HBA:
#RotB:
2.0
Source:
LODAPOLIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Melanoma; Neoplasms; Pancreatic Neoplasms
Unknown
LODAPOLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
NR4MAD6PPB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TALINOLOL
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Obesity, Morbid
Unknown
TALINOLOL
×
Maximum Phase:
1
First Approval:
None
UNII:
3S82268BKG
Molecule Type:
Small molecule
Molecular Formula:
C20H33N3O3
Molecular Weight:
363.5
AlogP:
3.27
PSA:
82.62
HBD:
4.0
HBA:
#RotB:
7.0
Source:
DTP-348
1
Small molecule
Investigational
Unknown
Unknown
Head and Neck Neoplasms
Unknown
DTP-348
×
Maximum Phase:
1
First Approval:
None
UNII:
2HB46A9CNM
Molecule Type:
Small molecule
Molecular Formula:
C6H11N5O4S
Molecular Weight:
249.25
AlogP:
-1.11
PSA:
133.15
HBD:
2.0
HBA:
#RotB:
5.0
Source:
SERCLUTAMAB TALIRINE
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
SERCLUTAMAB TALIRINE
×
Maximum Phase:
1
First Approval:
None
UNII:
7W0O278T12
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-1614235
1
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
GSK-1614235
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AVID200
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AVID200
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELGEMTUMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Squamous Cell; Esophageal Neoplasms
Receptor tyrosine-protein kinase erbB-3 inhibitor
ELGEMTUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
5F1CN52GFM
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MCAF5352A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MCAF5352A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
T84.66
1
Antibody
Investigational
Unknown
Unknown
Unknown
Carcinoembryonic antigen-related cell adhesion molecule 5 binding agent
T84.66
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VNRX-7145
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VNRX-7145
×
Maximum Phase:
1
First Approval:
None
UNII:
C5F376EKS2
Molecule Type:
Small molecule
Molecular Formula:
C19H26BNO7
Molecular Weight:
391.23
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FILOCICLOVIR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FILOCICLOVIR
×
Maximum Phase:
1
First Approval:
None
UNII:
EAO0TD9B13
Molecule Type:
Small molecule
Molecular Formula:
C11H13N5O3
Molecular Weight:
263.26
AlogP:
-1.08
PSA:
130.05
HBD:
4.0
HBA:
#RotB:
3.0
Source:
OSALMID
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
OSALMID
×
Maximum Phase:
1
First Approval:
None
UNII:
89741L759Z
Molecule Type:
Small molecule
Molecular Formula:
C13H11NO3
Molecular Weight:
229.24
AlogP:
2.35
PSA:
69.56
HBD:
3.0
HBA:
#RotB:
2.0
Source:
COMBRETASTATIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
COMBRETASTATIN
×
Maximum Phase:
1
First Approval:
None
UNII:
7O62J06F18
Molecule Type:
Small molecule
Molecular Formula:
C18H22O6
Molecular Weight:
334.37
AlogP:
2.7
PSA:
77.38
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ELTANEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ELTANEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
Q59IQJ9NTK
Molecule Type:
Small molecule
Molecular Formula:
C17H10F6N6O
Molecular Weight:
428.3
AlogP:
3.26
PSA:
99.58
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LY3415244
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LY3415244
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LMP-744
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Unknown
LMP-744
×
Maximum Phase:
1
First Approval:
None
UNII:
29BY7HQV0T
Molecule Type:
Small molecule
Molecular Formula:
C24H24N2O7
Molecular Weight:
452.46
AlogP:
1.93
PSA:
108.25
HBD:
2.0
HBA:
#RotB:
8.0
Source:
TUROFEXORATE ISOPROPYL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Bile acid receptor FXR agonist
TUROFEXORATE ISOPROPYL
×
Maximum Phase:
1
First Approval:
None
UNII:
S6KDM312I5
Molecule Type:
Small molecule
Molecular Formula:
C25H24F2N2O3
Molecular Weight:
438.47
AlogP:
5.17
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VALINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VALINE
×
Maximum Phase:
1
First Approval:
None
UNII:
HG18B9YRS7
Molecule Type:
Small molecule
Molecular Formula:
C5H11NO2
Molecular Weight:
117.15
AlogP:
0.05
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
2.0
Source:
AMV-564
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms
Unknown
AMV-564
×
Maximum Phase:
1
First Approval:
None
UNII:
56FUB33G5M
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLIAL GROWTH FACTOR 2
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
GLIAL GROWTH FACTOR 2
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NT-219
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NT-219
×
Maximum Phase:
1
First Approval:
None
UNII:
K1WT1A1UP5
Molecule Type:
Small molecule
Molecular Formula:
C16H14BrNO5S
Molecular Weight:
412.26
AlogP:
3.11
PSA:
113.18
HBD:
6.0
HBA:
#RotB:
4.0
Source:
BEPRANEMAB
1
Antibody
Investigational
Unknown
Unknown
Supranuclear Palsy, Progressive; Alzheimer Disease
Unknown
BEPRANEMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
9M1GV6L389
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TP-3654
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TP-3654
×
Maximum Phase:
1
First Approval:
None
UNII:
EOB0N7BOY4
Molecule Type:
Small molecule
Molecular Formula:
C22H25F3N4O
Molecular Weight:
418.46
AlogP:
5.16
PSA:
62.45
HBD:
2.0
HBA:
#RotB:
4.0
Source:
NU-3
1
Small molecule
Investigational
Unknown
Unknown
Infections
Unknown
NU-3
×
Maximum Phase:
1
First Approval:
None
UNII:
8BK3483OW5
Molecule Type:
Small molecule
Molecular Formula:
C18H32N2O11P2
Molecular Weight:
514.41
AlogP:
2.37
PSA:
175.61
HBD:
3.0
HBA:
#RotB:
14.0
Source:
REBAUDIOSIDE A
1
Oligosaccharide
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
REBAUDIOSIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
B3FUD0528F
Molecule Type:
Oligosaccharide
Molecular Formula:
C44H70O23
Molecular Weight:
967.02
AlogP:
-5.11
PSA:
374.13
HBD:
14.0
HBA:
#RotB:
12.0
Source:
BALAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BALAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PBF-999
1
Small molecule
Investigational
Unknown
Unknown
Huntington Disease; Neoplasms
Adenosine A2a receptor antagonist
PBF-999
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MSC2499550A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MSC2499550A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIO89-100
1
Unknown
Investigational
Unknown
Unknown
Hypertriglyceridemia; Non-alcoholic Fatty Liver Disease
Unknown
BIO89-100
×
Maximum Phase:
1
First Approval:
None
UNII:
UO870O6MFS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SYM-021
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SYM-021
×
Maximum Phase:
1
First Approval:
None
UNII:
K45ZNW8WU9
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
94
95
96
97
98
99
100
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA